FrancophonIA/ELRC3.0 huggingface dataset:
English: The most commonly reported adverse reactions (ADRs) are gastrointestinal, including nausea (38 %) and vomiting (23 %), especially during titration.
Slovenian: Najpogosteje so poročali o gastrointestinalnih neželenih učinkih, med drugim o navzei (38 %) in bruhanju (23 %), posebno med titriranjem odmerka.
English: Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted with rivastigmine in patients with dementia associated with Parkinson's disease with predefined adverse events that may reflect worsening of parkinsonian symptoms.
Slovenian: Preglednica 3 navaja število in delež bolnikov iz specifične 24-tedenske klinične študije z rivastigminom pri bolnikih z demenco, povezano s Parkinsonovo boleznijo, z vnaprej opredeljenimi neželenimi dogodki, ki lahko odražajo poslabšanje simptomov Parkinsonove bolezni.
English: If treatment is interrupted for more than three days, it should be re-initiated at 1.5 mg twice daily to reduce the possibility of adverse reactions (e.g. vomiting).
Slovenian: Če zdravljenje prekinemo za več kot tri dni, ga moramo spet začeti z odmerkom 1,5 mg dvakrat na dan, da zmanjšamo možnost neželenih učinkov (npr. bruhanje).
English: • Bleeding in the gut - shows as blood in stools or when being sick
Slovenian: • Krvavitev iz črevesja - kaže se kot kri v blatu ali pri bruhanju
English: Rivastigmine Actavis might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson's disease or to prevent travel sickness).
Slovenian: Zdravilo Rivastigmin Actavis bi lahko vplivalo na zdravljenje z antiholinergičnimi zdravili (zdravili, ki se uporabljajo za lajšanje želodčnih krčev ali spazmov, za zdravljenje Parkinsonove bolezni ali za preprečevanje slabosti na potovanju).
English: Hypertension Hypotension
Slovenian: Hipertenzija Hipotenzija
English: Slow heartbeat and fainting may also occur.
Slovenian: Lahko se pojavita tudi upočasnjen srčni utrip in omedlevica.
English: Atrial Fibrillation
Slovenian: Atrijska fibrilacija
English: Less than 1 % of the administered dose is excreted in the faeces.
Slovenian: Manj kot 1 % zaužitega odmerka se izloči z blatom.
English: Patients with moderate
Slovenian: Bolniki z zmerno
English: The results for clinically relevant responders pooled from two flexible dose studies out of the three pivotal 26-week multicentre studies in patients with mild-to-moderately severe Alzheimer's Dementia, are provided in Table 4 below.
Slovenian: Rezultate bolnikov, ki so se klinično pomembno odzvali na zdravljenje, združene iz dveh študij prilagojenih odmerkov od treh ključnih 26-tedenskih multicentričnih študij pri bolnikih z blago do zmerno težko Alzheimerjevo demenco, podaja spodnja Preglednica 4.
English: • Inflammation of the pancreas - the signs include serious upper stomach pain, often with feeling sick (nausea) or being sick (vomiting)
Slovenian: • Vnetje trebušne slinavke - znaki vključujejo hudo bolečino v zgornjem delu trebuha, pogosto z občutkom slabosti (navzeo) in bruhanjem
English: In healthy young men, an oral 3 mg dose decreases acetylcholinesterase (AChE) activity in CSF by approximately 40 % within the first 1.5 hours after administration.
Slovenian: Pri zdravih mladih moških peroralni odmerek 3 mg zmanjša aktivnost acetilholinesteraze (AChE) v cerebrospinalni tekočini (CSF) za približno 40 % v poldrugi uri po zaužitju.
English: Some people who have accidentally taken too much Rivastigmine Actavis have experienced feeling sick (nausea), being sick (vomiting), diarrhoea, high blood pressure and hallucinations.
Slovenian: Pri nekaterih ljudeh, ki so pomotoma vzeli preveč zdravila Rivastigmin Actavis, so se pojavili siljenje na bruhanje (navzea), bruhanje, driska, zvišan krvni tlak in halucinacije.
English: Adverse reactions in Table 1 and Table 2 are listed according to MedDRA system organ class and frequency category.
Slovenian: V Preglednici 1 in Preglednici 2 so neželeni učinki navedeni glede na organski sistem po MedDRA klasifikaciji in glede na kategorijo pogostnosti.
English: • Depression
Slovenian: • Depresija
English: • if you have, or have ever had, asthma or severe respiratory disease.
Slovenian: • če imate ali če ste kdaj imeli astmo ali hudo bolezen dihal.
English: PHARMACEUTICAL FORM AND CONTENTS 250 hard capsules
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA 250 trdih kapsul
English: Allergic contact dermatitis should be suspected if application site reactions spread beyond the patch size, if there is evidence of a more intense local reaction (e.g. increasing erythema, oedema, papules, vesicles) and if symptoms do not significantly improve within 48 hours after patch removal.
Slovenian: Na alergijski kontaktni dermatitis je treba pomisliti v primeru, da se reakcija na mestu apliciranja razširi preko površine, ki jo pokriva obliž, in je mogoče opaziti večjo izraženost lokalne reakcije (na primer vse bolj izražen eritem, edem, papularen ali vezikulozen izpuščaj), simptomi pa se v 48 urah po odstranitvi obliža bistveno ne izboljšajo.
English: These include the ADAS-Cog (Alzheimer's Disease Assessment Scale - Cognitive subscale, a performance based measure of cognition), the CIBIC-Plus (Clinician's Interview Based Impression of Change-Plus, a comprehensive global assessment of the patient by the physician incorporating caregiver input), and the PDS (Progressive Deterioration Scale, a caregiver-rated assessment of the activities of daily living including personal hygiene, feeding, dressing, household chores such as shopping, retention of ability to orient oneself to surroundings as well as involvement in activities relating to finances, etc.).
Slovenian: Med njimi so ADAS-Cog (Alzheimer's Disease Assessment Scale - Cognitive subscale, Lestvica za oceno kognitivnih sposobnosti bolnikov z Alzheimerjevo boleznijo, merilo kognitivne zmogljivosti, ki temelji na izvrševanju aktivnosti), CIBIC-Plus (Clinician's Interview Based Impression of ChangePlus, Zdravnikova ocena spremembe bolezni na podlagi pogovora, celostno globalno ocenjevanje bolnika, ki ga opravlja zdravnik in ki zajema tudi podatke, ki jih daje/-jo negovalec/-ci) in PDS (Progressive Deterioration Scale, Lestvica progresivnega slabšanja, negovalčeva ocena vsakodnevnih aktivnosti, na primer osebne higiene, hranjenja, oblačenja,gospodinjskih opravil, na primer nakupovanja, ohranjanje zmožnosti orientacije v okolju, pa tudi ukvarjanje z denarnimi zadevami itn.).
English: The following adverse reactions, listed below in Table 1, have been accumulated in patients with Alzheimer's dementia treated with rivastigmine.
Slovenian: Neželene učinke, navedene v spodnji Preglednici 1, so zbrali pri bolnikih z Alzheimerjevo demenco, zdravljenih z rivastigminom.
English: Pruritus, allergic dermatitis (disseminated)
Slovenian: Srbenje, alergijski dermatitis (diseminirana oblika)
English: By blocking these enzymes, Rivastigmine Actavis allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer's disease and dementia associated with Parkinson's disease.
Slovenian: Zdravilo Rivastigmin Actavis z zaviranjem navedenih encimov omogoča zvišanje koncentracije acetilholina v možganih in s tem pomaga pri zmanjševanju simptomov Alzheimerjeve bolezni in demence v povezavi s Parkinsonovo boleznijo.
English: Table 2 shows the adverse reactions reported during clinical studies conducted in patients with dementia associated with Parkinson's disease treated with rivastigmine capsules.
Slovenian: Preglednica 2 prikazuje neželene učinke, o katerih so poročali iz kliničnih študij, ki so jih izvajali pri bolnikih z demenco, povezano s Parkinsonovo boleznijo, zdravljenih s kapsulami rivastigmina.
English: • Liver disorders (yellow skin, yellowing of the whites of the eyes, abnormal darkening of the urine or unexplained nausea, vomiting, tiredness and loss of appetite)
Slovenian: • Jetrne motnje (porumenelost kože, porumenelost očesnih beločnic, nenormalno temen urin ali nepojasnjena slabost v želodcu, bruhanje, utrujenost in izguba apetita)
English: Similarly a larger treatment effect was observed in those patients with visual hallucinations (see Table 6).
Slovenian: Prav tako so boljši učinek opazili pri tistih bolnikih, ki so imeli vidne halucinacije (glejte Preglednico 6).
English: • Aggression, feeling restless
Slovenian: • Agresivnost, občutek nemira
English: A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IZDELOVALEC(IZDELOVALCI), ODGOVOREN (ODGOVORNI) ZA SPROŠČANJE SERIJ
English: Do not take Rivastigmine Actavis
Slovenian: Ne jemljite zdravila Rivastigmin Actavis
English: NAME OF THE MARKETING AUTHORISATION HOLDER [Actavis logo]
Slovenian: IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM [Actavis logotip]
English: • if you have a skin reaction spreading beyond the patch size, if there is a more intense local reaction (such as blisters, increasing skin inflammation, swelling) and if it does not improve within 48 hours after removal of the transdermal patch.
Slovenian: • če opazite kožno reakcijo, ki se širi preko površine, ki jo pokriva transdermalni obliž, če je reakcija na tem mestu močneje izražena (če se pojavijo mehurčki, če je vnetje oziroma oteklina vse bolj izrazita) in če se ti znaki v 48 urah po odstranitvi transdermalnega obliža ne izboljšajo.
English: Previous history of application site reactions suggestive of allergic contact dermatitis with rivastigmine patch (see section 4.4).
Slovenian: Anamneza reakcije na mestu apliciranja, ki bi bile lahko znak alergijskega kontaktnega dermatitisa pri uporabi transdermalnih obližev z rivastigminom (glejte poglavje 4.4).
English: Restlessness Hallucination, visual Depression
Slovenian: Vidne halucinacije Depresija Agresivnost
English: Therefore, women on rivastigmine should not breast-feed.
Slovenian: Zato matere, ki jemljejo rivastigmin, ne smejo dojiti.
English: • The signs of Parkinson's disease get worse or getting similar signs - such as stiff muscles,
Slovenian: • Poslabšanje znakov Parkinsonove bolezni ali pojav podobnih znakov - na primer togih mišic ali težav pri izvajanju gibov
English: Capsule content: Magnesium stearate, colloidal anhydrous silica, hypromellose and microcrystalline cellulose.
Slovenian: Vsebina kapsule: magnezijev stearat, brezvoden koloidni silicijev dioksid, hipromeloza in mikrokristalna celuloza.
English: Placebo of parkinsonian symptoms in patients with dementia n (%)
Slovenian: Placebo odražajo poslabšanje simptomov Parkinsonove bolezni pri bolnikih z demenco, povezano s Parkinsonovo boleznijo n (%)
English: Rivastigmine Actavis may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.
Slovenian: Zdravilo Rivastigmin Actavis lahko povzroči vrtoglavost in zaspanost, predvsem na začetku zdravljenja ali ob povečanju odmerka.
English: The Cmax of rivastigmine was approximately 60 % higher and the AUC of rivastigmine was more than twice as high in subjects with mild to moderate hepatic impairment than in healthy subjects.
Slovenian: Cmax rivastigmina je bila za približno 60 % večja in AUC rivastigmina več kot dvakrat večja pri osebah z blago do zmerno jetrno okvaro kot pri zdravih osebah.
English: Patients with severe hepatic impairment have not been studied, however, Rivastigmine Actavis capsules may be used in this patient population provided close monitoring is exercised (see section 4.4 and 5.2).
Slovenian: Uporabe zdravila pri bolnikih s težko jetrno okvaro niso proučili, bolniki iz te populacije lahko kljub temu uporabljajo zdravilo Rivastigmin Actavis v obliki kapsul, vendar jih je treba skrbno spremljati (glejte poglavji 4.4 in
English: • Problems with your heartbeat such as fast or slow heartbeat
Slovenian: • Motnje srčnega ritma, kot sta prepočasen ali prehiter srčni utrip
English: The following additional adverse reaction has been observed in a study of patients with dementia associated with Parkinson's disease treated with rivastigmine transdermal patches: agitation (common).
Slovenian: Naslednji neželeni učinek so, poleg že navedenih, opažali v študiji pri bolnikih, ki so imeli demenco v povezavi s Parkinsonovo boleznijo in so bili zdravljeni s transdermalnimi obliži z rivastigminom: agitiranost (pogosti).
English: There is no relevant use of Rivastigmine Actavis in the paediatric population in the treatment of Alzheimer's disease.
Slovenian: Zdravila Rivastigmin Actavis ni smiselno uporabljati pri pediatrični populaciji za zdravljenje Alzheimerjeve bolezni.
English: Allergic dermatitis (disseminated)
Slovenian: Hiperhidroza Alergijski dermatitis (diseminirana oblika)
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER [Actavis logo]
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM [Actavis logotip]
English: Uncommon (may affect up to 1 in 100 people) • Uneven heartbeat and poor control of movements
Slovenian: Občasni (pojavijo se lahko pri največ 1 od 100 bolnikov) • Nepravilen srčni utrip in motnje koordinacije gibov
English: Rivastigmine might interfere with the activity of anticholinergic medicinal products (e.g oxybutynin, tolterodine).
Slovenian: Rivastigmin lahko moti delovanje antiholinergičnih zdravil (na primer oksibutinina in tolterodina).
English: • if you have, or have ever had, irregular or slow heartbeat.
Slovenian: • če imate ali ste kdaj imeli nepravilen ali počasen srčni utrip.
English: Motor dysfunction
Slovenian: Rigor Motorične motnje
English: Infections and infestations Very rare
Slovenian: Infekcijske in parazitske bolezni Zelo redki
English: • Decreased appetite
Slovenian: • Zmanjšan apetit
English: There is no relevant use of rivastigmine in the paediatric population in the treatment of Alzheimer's disease.
Slovenian: Pediatrična populacija Rivastigmina ni smiselno uporabljati pri pediatrični populaciji za zdravljenje Alzheimerjeve bolezni.
English: Rivastigmine was not mutagenic in a standard battery of in vitro and in vivo tests, except in a chromosomal aberration test in human peripheral lymphocytes at a dose 10
Slovenian: V standardni bateriji testov in vitro in in vivo rivastigmin ni bil mutagen, razen v testu kromosomskih
English: Rivastigmine Actavis should not be given at the same time as metoclopramide (a medicine used to relieve or prevent nausea and vomiting).
Slovenian: Zdravila Rivastigmin Actavis ne smete jemati sočasno z metoklopramidom (zdravilom, ki ga uporabljamo za ublažitev ali preprečevanje navzee (slabosti s siljenjem na bruhanje) in bruhanja).
English: Dementia associated with ADAS-Cog ADAS-Cog ADCS- CGIC ADCS-CGIC Parkinson's Disease
Slovenian: ADAS-Cog ADAS-Cog ADCS- CGIC ADCS-CGIC Parkinsonovo boleznijo Rivastigmin Placebo Rivastigmin Placebo
English: Magnesium stearate Silica colloidal, anhydrous Hypromellose Microcrystalline cellulose
Slovenian: magnezijev stearat brezvoden koloidni silicijev dioksid hipromeloza mikrokristalna celuloza
English: The following additional adverse reactions have been observed with rivastigmine transdermal patches: delirium, pyrexia, decreased appetite, urinary incontinence (common), psychomotor hyperactivity (uncommon), erythema, urticaria, vesicles, allergic dermatitis (not known).
Slovenian: Pri uporabi transdermalnih obližev rivastigmina so dodatno opažali še naslednje neželene učinke: delirij, zvišano telesno temperaturo, zmanjšan apetit, urinska inkontinenca (pogosto), psihomotorična hiperaktivnost (občasno), eritem, urtikarija, mehurčki, alergijski dermatitis (pogostnost neznana).
English: The active substance of Rivastigmine Actavis is rivastigmine.
Slovenian: Zdravilna učinkovina v zdravilu Rivastigmin Actavis je rivastigmin.
English: • The highest dose that should be taken is 6 mg twice a day.
Slovenian: • Najvišji dovoljeni odmerek je 6 mg dvakrat na dan.
English: How to take Rivastigmine Actavis
Slovenian: Kako jemati zdravilo Rivastigmin Actavis
English: • Fainting or accidentally falling
Slovenian: • Omedlevica ali nezgodni padci
English: You should not breast-feed during treatment with Rivastigmine Actavis.
Slovenian: Med zdravljenjem z zdravilom Rivastigmin Actavis ne smete dojiti.
English: • Accidentally falling
Slovenian: • Nezgodni padec
English: 1.5 mg twice a day.
Slovenian: Začetni odmerek 1,5 mg dvakrat na dan.
English: If you are pregnant, the benefits of using Rivastigmine Actavis must be assessed against the possible effects on your unborn child. Rivastigmine Actavis should not be used during pregnancy, unless clearly necessary.
Slovenian: V primeru, da ste noseči, je treba pretehtati koristi uporabe zdravila Rivastigmin Actavis in možne učinke na nerojenega otroka.
English: • Being violently sick (vomiting) that can cause tearing of the tube that connects your mouth with your stomach (oesophagus)
Slovenian: • Močno bruhanje, ki lahko povzroči raztrganje požiralnika (cevi med usti in želodcem)
English: Dementia associated with ADAS-Cog ADAS-Cog ADAS-Cog ADAS-Cog Parkinson's Disease
Slovenian: ADAS-Cog ADAS-Cog ADAS-Cog ADAS-Cog Parkinsonovo boleznijo Rivastigmin Placebo Rivastigmin Placebo
English: Caution when Rivastigmine Actavis is taken together with beta-blockers (medicines such as atenolol used to treat hypertension, angina and other heart conditions).
Slovenian: Previdnost je potrebna pri sočasni uporabi zdravila Rivastigmin Actavis in katerega od antagonistov adrenergičnih receptorjev beta (učinkovin, kot je atenolol, ki ga uporabljamo za zdravljenje visokega krvnega tlaka, angine pektoris in drugih bolezni srca).
English: The ink may or may not contain potassium hydroxide.
Slovenian: Črnilo lahko vsebuje kalijev hidroksid.
English: Not known
Slovenian: Pogostnost neznana
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 16 June 2011
Slovenian: Datum prve odobritve: 16.
English: Dose titration: Adverse reactions (e.g. hypertension and hallucinations in patients with Alzheimer's dementia and worsening of extrapyramidal symptoms, in particular tremor, in patients with dementia associated with Parkinson's disease) have been observed shortly after dose increase.
Slovenian: Titriranje odmerka: V kratkem času po povečanju odmerka so opazili neželene učinke (npr. hipertenzijo in halucinacije pri bolnikih z Alzheimerjevo demenco in poslabšanje ekstrapiramidnih simptomov, zlasti tremorja, pri bolnikih z demenco v povezavi s Parkinsonovo boleznijo).
English: • Fits (seizures)
Slovenian: • Napadi krčev (epileptični napadi)
English: Mean change at 24 weeks 2.5 ± 8.4 ± SD
Slovenian: Povprečna sprememba po 2,5 ± 8,4 24 tednih ± SD
English: Shellac, propylene glycol, red iron oxide (E172).
Slovenian: Tiskarsko črnilo: šelak, propilenglikol, rdeči železov oksid (E172).
English: • if you have, or have ever had, difficulties in passing urine.
Slovenian: • če imate ali če ste kdaj imeli težave z uriniranjem.
English: • if you have gastrointestinal reactions such as feeling sick (nausea), being sick (vomiting) and diarrhoea.
Slovenian: • če imate prebavne težave, kot so slabost s siljenjem na bruhanje (navzea), bruhanje in driska.
English: Cardiac disorders Rare
Slovenian: Srčne bolezni Redki
English: - If you have any further questions, ask your doctor, pharmacist or nurse.
Slovenian: - Če imate dodatna vprašanja, se posvetujte z zdravnikom, farmacevtom ali z medicinsko sestro.
English: • Changes in how well your liver is working
Slovenian: • Spremembe v delovanju jeter
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR CAPSULE CONTAINER
Slovenian: PODATKI NA ZUNANJI OVOJNINI ŠKATLA ZA VSEBNIK ZA KAPSULE
English: • Stomach problems such as feeling sick (nausea) or being sick (vomiting), diarrhoea
Slovenian: • Prebavne težave, kot so navzea (slabost s siljenjem na bruhanje) ali bruhanje, driska
English: Rivastigmine Actavis 1.5 mg hard capsules Rivastigmine Actavis 3 mg hard capsules Rivastigmine Actavis 4.5 mg hard capsules Rivastigmine Actavis 6 mg hard capsules rivastigmine
Slovenian: Rivastigmin Actavis 1,5 mg trde kapsule Rivastigmin Actavis 3 mg trde kapsule Rivastigmin Actavis 4,5 mg trde kapsule Rivastigmin Actavis 6 mg trde kapsule
English: • if you have, or have ever had, an active stomach ulcer.
Slovenian: • če imate ali ste kdaj imeli aktivno želodčno razjedo.
English: Muscle rigidity
Slovenian: Mišična rigidnost
English: Some cases of severe vomiting were associated with oesophageal rupture (see section 4.4).
Slovenian: V nekaterih primerih je bilo hudo bruhanje povezano z rupturo požiralnika (glejte poglavje 4.4)
English: • Feeling restless
Slovenian: • Občutek nemira
English: Vascular disorders Very rare
Slovenian: Žilne bolezni Zelo redki
English: Rivastigmine Placebo Rivastigmine Placebo Patients with visual
Slovenian: Rivastigmin Placebo Rivastigmin Placebo 6-12 mg
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Actavis Group PTC ehf.
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Actavis Group PTC ehf.
English: Mean change at 24 weeks 2.1 ± 8.2 ± SD
Slovenian: Povprečna sprememba po 2,1 ± 8,2 24 tednih ± SD
English: • Ulcers in your stomach or intestine
Slovenian: • Razjede želodca ali črevesja
English: Pre-defined adverse events that may reflect worsening Rivastigmine
Slovenian: Vnaprej opredeljeni neželeni dogodki, ki lahko
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL FOR CAPSULE CONTAINER
Slovenian: PODATKI NA STIČNI OVOJNINI NALEPKA ZA VSEBNIK ZA KAPSULE
English: INFORMATION IN BRAILLE Rivastigmine Actavis 1.5 mg
Slovenian: PODATKI V BRAILLOVI PISAVI Rivastigmin Actavis 1,5 mg
English: INFORMATION IN BRAILLE Rivastigmine Actavis 4.5 mg
Slovenian: PODATKI V BRAILLOVI PISAVI Rivastigmin Actavis 4,5 mg
English: • Headache
Slovenian: • Glavobol
English: INFORMATION IN BRAILLE Rivastigmine Actavis 6 mg
Slovenian: PODATKI V BRAILLOVI PISAVI Rivastigmin Actavis 6 mg
English: Rivastigmine Actavis 3 mg, 4.5 mg and 6 mg hard capsules: Red iron oxide (E172), titanium dioxide (E171), yellow iron oxide (E172) and gelatine.
Slovenian: Rivastigmin Actavis 3 mg, 4,5 mg in 6 mg trde kapsule: rdeči železov oksid (E172), titanov dioksid (E171), rumeni železov oksid (E172) in želatina.
English: Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristic, section 4.2).
Slovenian: B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja zdravila je le s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
English: Nightmares Agitation
Slovenian: Nočne more
English: Initial dose
Slovenian: Povprečje ob izhodišču ±
English: Reykjavíkurvegur 76-78 220 Hafnarfjörður Iceland
Slovenian: Reykjavíkurvegur 76-78 220 Hafnarfjörður Islandija
English: Each Rivastigmine Actavis 6 mg capsule contains 6 mg of rivastigmine.
Slovenian: Ena kapsula zdravila Rivastigmin Actavis 6 mg vsebuje 6 mg rivastigmina.
English: INFORMATION IN BRAILLE Rivastigmine Actavis 3 mg
Slovenian: PODATKI V BRAILLOVI PISAVI Rivastigmin Actavis 3 mg
English: General disorders and administrationsite conditions
Slovenian: Splošne težave in spremembe na mestu aplikacije
English: Each Rivastigmine Actavis 4.5 mg capsule contains 4.5 mg of rivastigmine.
Slovenian: Ena kapsula zdravila Rivastigmin Actavis 4,5 mg vsebuje 4,5 mg rivastigmina.
English: Each Rivastigmine Actavis 1.5 mg capsule contains 1.5 mg of rivastigmine.
Slovenian: Ena kapsula zdravila Rivastigmin Actavis 1,5 mg vsebuje 1,5 mg rivastigmina.
English: Rivastigmine Actavis 1.5 mg hard capsules Titanium dioxide (E171) Yellow iron oxide (E172) Gelatine
Slovenian: Rivastigmin Actavis 1,5 mg trde kapsule titanov dioksid (E171) rumeni železov oksid (E172) želatina
English: • Nightmares
Slovenian: • Nočne more
English: Metabolism and nutrition disorders Common
Slovenian: Presnovne in prehranske motnje
English: What Rivastigmine Actavis looks like and contents of the pack - Rivastigmine Actavis 1.5 mg hard capsules, which contain off-white to slightly yellow powder, have a yellow cap and yellow body, with red imprint “RIV 1.5mg” on body.
Slovenian: Izgled zdravila Rivastigmin Actavis in vsebina pakiranja Rivastigmin Actavis 1,5 mg trde kapsule, ki vsebujejo belkast do rahlo rumen prašek, imajo rumen pokrovček in rumeno telo z rdečim napisom “RIV 1,5mg” na telesu.
English: Rivastigmine Actavis 4.5 mg hard capsules
Slovenian: Rivastigmin Actavis 4,5 mg trde kapsule